Related references
Note: Only part of the references are listed.Quality of life and mental health in breast cancer survivors compared with non-cancer controls: a study of patient-reported outcomes in the United Kingdom
Helena Carreira et al.
JOURNAL OF CANCER SURVIVORSHIP (2021)
C-phycocyanin Mitigates Cognitive Impairment in Doxorubicin-Induced Chemobrain: Impact on Neuroinflammation, Oxidative Stress, and Brain Mitochondrial and Synaptic Alterations
Chenying Wang et al.
NEUROCHEMICAL RESEARCH (2021)
Neuropsychological functioning among patients with different types of cancer Postchemotherapy cognitive impairment and implications for rehabilitation
Kalliopi Megari
NEUROPSYCHIATRIE (2021)
Gray Matter Structural Network Disruptions in Survivors of Acute Lymphoblastic Leukemia with Chemotherapy Treatment
Longsheng Wang et al.
ACADEMIC RADIOLOGY (2020)
4Chemobrain in rats: Behavioral, morphological, oxidative and inflammatory effects of doxorubicin administration
Carolina Vieira Cardoso et al.
BEHAVIOURAL BRAIN RESEARCH (2020)
Cognitive impairments in breast cancer survivors treated with chemotherapy: a study based on event-related potentials
Zhou Xu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)
The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer
Hayley S. Whitford et al.
SUPPORTIVE CARE IN CANCER (2020)
Effects of chemotherapy on aging white matter microstructure: A longitudinal diffusion tensor imaging study
Bihong T. Chen et al.
JOURNAL OF GERIATRIC ONCOLOGY (2020)
Chemotherapy-induced functional changes of the default mode network in patients with lung cancer
Yujie Zhang et al.
BRAIN IMAGING AND BEHAVIOR (2020)
Polydatin ameliorates chemotherapy-induced cognitive impairment (chemobrain) by inhibiting oxidative stress, inflammatory response, and apoptosis in rats
Yifan Tong et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2020)
Differential DNA methylation following chemotherapy for breast cancer is associated with lack of memory improvement at one year
Gee Su Yang et al.
EPIGENETICS (2020)
Neurophysiologic and ophthalmic markers of chemotherapy-related cognitive impairment in patients diagnosed with hematologic cancer: A feasibility study
David E. Anderson et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Cortical Brain Age from Pre-treatment to Post-chemotherapy in Patients with Breast Cancer
Ashley Henneghan et al.
NEUROTOXICITY RESEARCH (2020)
Screening for cognitive impairment in older adults with hematological malignancies using the Montreal Cognitive Assessment and neuropsychological testing
Thuy T. Koll et al.
JOURNAL OF GERIATRIC ONCOLOGY (2020)
Type of cancer treatment and cognitive symptoms in working cancer survivors: an 18-month follow-up study
Johanna K. Ehrenstein et al.
JOURNAL OF CANCER SURVIVORSHIP (2020)
Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases
Lien D. Nguyen et al.
EMBO MOLECULAR MEDICINE (2020)
Connectome analysis of brain functional network alterations in breast cancer survivors with and without chemotherapy
Vincent Chin-Hung Chen et al.
PLOS ONE (2020)
Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment
AnnaLynn M. Williams et al.
LEUKEMIA & LYMPHOMA (2020)
Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab: Insights to neuroimmune mechanistic hallmarks
Sara A. Wandan et al.
NEUROCHEMISTRY INTERNATIONAL (2020)
Effect of Metformin on Doxorubicin-Induced Memory Dysfunction
Ibrahim Alharbi et al.
BRAIN SCIENCES (2020)
Network-level functional connectivity alterations in chemotherapy treated breast cancer patients: a longitudinal resting state functional MRI study
Yun Feng et al.
CANCER IMAGING (2020)
Caffeic acid phenethyl ester counteracts doxorubicin-induced chemobrain in Sprague-Dawley rats: Emphasis on the modulation of oxidative stress and neuroinflammation
Marwa A. Ali et al.
NEUROPHARMACOLOGY (2020)
Modulation of Interhemispheric Functional Coordination in Breast Cancer Patients Receiving Chemotherapy
Longxiang Tao et al.
FRONTIERS IN PSYCHOLOGY (2020)
Cognitive functioning in long-term cancer survivorship: A survey utilizing both standardized neuropsychological and self-report measures
Barbara Muzzatti et al.
APPLIED NEUROPSYCHOLOGY-ADULT (2019)
Effects of Adjuvant Chemotherapy on Cognitive Function of Patients With Early-stage Colorectal Cancer
Manuela Vasconcelos Castro Sales et al.
CLINICAL COLORECTAL CANCER (2019)
Impaired brain dopamine transporter in chemobrain patients submitted to brain SPECT imaging using the technetium-99m labeled tracer TRODAT-1
Taise Vitor et al.
ANNALS OF NUCLEAR MEDICINE (2019)
Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (chemobrain), a condition that significantly impairs the quality of life of many cancer survivors
Xiaojia Ren et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Immediate-term cognitive impairment following intravenous (IV) chemotherapy: a prospective pre-post design study
Omar F. Khan et al.
BMC CANCER (2019)
Episodic memory for visual scenes suggests compensatory brain activity in breast cancer patients: a prospective longitudinal fMRI study
Denise Pergolizzi et al.
BRAIN IMAGING AND BEHAVIOR (2019)
Assessment and management of cognitive changes in patients with cancer
Michael W. Parsons et al.
CANCER (2019)
Adaptogens in chemobrain (Part I): Plant extracts attenuate cancer chemotherapy-induced cognitive impairment - Transcriptome-wide microarray profiles of neuroglia cells
Ean-Jeong Seo et al.
PHYTOMEDICINE (2019)
Changes in functional brain networks and neurocognitive function in Chinese gynecological cancer patients after chemotherapy: a prospective longitudinal study
Yingchun Zeng et al.
BMC CANCER (2019)
Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain
Sara Emad El-Agamy et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
The triangle of death of neurons: Oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment (chemobrain) involving TNF-α
Xiaojia Ren et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Chemotherapy-induced cognitive impairments: A systematic review of the animal literature
A. Matsos et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Age-dependent brain volume and neuropsychological changes after chemotherapy in breast cancer patients
Jeroen Blommaert et al.
HUMAN BRAIN MAPPING (2019)
Protective Effects of ACY-1215 Against Chemotherapy-Related Cognitive Impairment and Brain Damage in Mice
Dongmei Wang et al.
NEUROCHEMICAL RESEARCH (2019)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2019)
5-Fluorouracil impairs attention and dopamine release in rats
David P. Jarmolowicz et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
Attenuation of neuroinflammation reverses Adriamycin-induced cognitive impairments
Barrett D. Allen et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Cognitive performance in survivors of breast cancer and markers of biological aging
Judith E. Carroll et al.
CANCER (2019)
Clearing the Fog surrounding Chemobrain
David H. Gutmann
CELL (2019)
Methotrexate Chemotherapy Induces Persistent Tri-glial Dysregulation that Underlies Chemotherapy-Related Cognitive Impairment
Erin M. Gibson et al.
CELL (2019)
Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results
Noemi Cerulla et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2019)
Association of functional dorsal attention network alterations with breast cancer and chemotherapy
Chao-Yu Shen et al.
SCIENTIFIC REPORTS (2019)
Brain connectivity tracks effects of chemotherapy separately from behavioral measures
Omid Kardan et al.
NEUROIMAGE-CLINICAL (2019)
Astaxanthin Ameliorates Doxorubicin-Induced Cognitive Impairment (Chemobrain) in Experimental Rat Model: Impact on Oxidative, Inflammatory, and Apoptotic Machineries
Sara Emad El-Agamy et al.
MOLECULAR NEUROBIOLOGY (2018)
Treatment With Chemotherapy and Cognitive Functioning in Older Adult Cancer Survivors
Ruth T. Morin et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2018)
Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy
AnnaLynn M. Williams et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
Naringin Ameliorates Doxorubicin-induced Neurotoxicity In vitro and Cognitive Dysfunction In vivo
Grandhi Venkata Ramalingayya et al.
PHARMACOGNOSY MAGAZINE (2018)
The timeliness of patients reporting the side effects of chemotherapy
Ian Olver et al.
SUPPORTIVE CARE IN CANCER (2018)
Recent cancer treatment and memory decline in older adults: An analysis of the 2002-2012 Health and Retirement Study
Krystle E. Zuniga et al.
JOURNAL OF GERIATRIC ONCOLOGY (2018)
Neurocognitive deficits in older patients with cancer
Beatrice J. Edwards et al.
JOURNAL OF GERIATRIC ONCOLOGY (2018)
Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity
Jacopo Junio Valerio Branca et al.
Oncotarget (2018)
Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”)
Jeriel T.R. Keeney et al.
Oncotarget (2018)
Performance monitoring in lung cancer patients pre- and post-chemotherapy using fine-grained electrophysiological measures
M. Simo et al.
NEUROIMAGE-CLINICAL (2018)
Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer
Bihong T. Chen et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Distinct attentional function profiles in older adults receiving cancer chemotherapy
Inger Utne et al.
EUROPEAN JOURNAL OF ONCOLOGY NURSING (2018)
Diminished gray matter density mediates chemotherapy dosage-related cognitive impairment in breast cancer patients
Xiu Li et al.
SCIENTIFIC REPORTS (2018)
Investigation of chemotherapy-induced brain structural alterations in breast cancer patients with generalized q-sampling MRI and graph theoretical analysis
Tsung-Yuan Li et al.
BMC CANCER (2018)
The involvement of autophagic flux in the development and recovery of doxorubicin-induced neurotoxicity
Xueyuan Zhou et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
The role of cellular reactive oxygen species in cancer chemotherapy
Haotian Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Cisplatin treatment induces attention deficits and impairs synaptic integrity in the prefrontal cortex in mice
XiaoJiao Huo et al.
SCIENTIFIC REPORTS (2018)
Mitoxantrone is More Toxic than Doxorubicin in SH-SY5Y Human Cells: A Chemobrain' In Vitro Study
Daniela Almeida et al.
PHARMACEUTICALS (2018)
Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study
Sanne Menning et al.
BRAIN IMAGING AND BEHAVIOR (2018)
Cognitive function following breast cancer treatment and associations with concurrent symptoms
Kathleen Van Dyk et al.
NPJ BREAST CANCER (2018)
Management of side effects during and post-treatment in breast cancer survivors
Oxana Palesh et al.
BREAST JOURNAL (2018)
Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: a pilot study
D. D. Correa et al.
BRAIN IMAGING AND BEHAVIOR (2017)
Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis
Mi Sook Jung et al.
BRAIN IMAGING AND BEHAVIOR (2017)
Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment
Ali Amidi et al.
BRAIN IMAGING AND BEHAVIOR (2017)
Impairment of the executive function in breast cancer patients receiving chemotherapy treatment: a functional MRI study
L. Tao et al.
EUROPEAN JOURNAL OF CANCER CARE (2017)
Altered intrinsic brain activity after chemotherapy in patients with gastric cancer: A preliminary study
Hyun Gi Kim et al.
EUROPEAN RADIOLOGY (2017)
Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats
Naomi Lomeli et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Defining cancer survivors, their needs, and perspectives on survivorship health care in the USA
Deborah K. Mayer et al.
LANCET ONCOLOGY (2017)
Dysregulation of cytokine mediated chemotherapy induced cognitive impairment
Xiaojia Ren et al.
PHARMACOLOGICAL RESEARCH (2017)
Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type
Sanne Menning et al.
PLOS ONE (2017)
Induction of oxidative stress by anticancer drugs in the presence and absence of cells
Chikako Yokoyama et al.
ONCOLOGY LETTERS (2017)
Growth of malignant extracranial tumors alters microRNAome in the prefrontal cortex of TumorGraft mice
Anna Kovalchuk et al.
ONCOTARGET (2017)
Chemotherapy-induced changes of cerebral activity in resting-state functional magnetic resonance imaging and cerebral white matter in diffusion tensor imaging
Caiqin Mo et al.
ONCOTARGET (2017)
Altered resting-state hippocampal functional networks associated with chemotherapy-induced prospective memory impairment in breast cancer survivors
Huaidong Cheng et al.
SCIENTIFIC REPORTS (2017)
Acute treatment with doxorubicin affects glutamate neurotransmission in the mouse frontal cortex and hippocampus
Theresa Currier Thomas et al.
BRAIN RESEARCH (2017)
Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study
Noemi Cerulla et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Cognitive impairment in the first year after breast cancer diagnosis: A prospective cohort study
Mariana Ramalho et al.
BREAST (2017)
Quality of life in long-term and very long-term cancer survivors versus population controls in Germany
Volker Arndt et al.
ACTA ONCOLOGICA (2017)
Reduced prefrontal activation during working and long-term memory tasks and impaired patient-reported cognition among cancer survivors postchemotherapy compared with healthy controls
Lei Wang et al.
CANCER (2016)
Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer
Terence Ng et al.
NEURO-ONCOLOGY (2016)
TFEB ameliorates the impairment of the autophagy-lysosome pathway in neurons induced by doxorubicin
Jose Felix Moruno Manchon et al.
AGING-US (2016)
Neurobiological changes by cytotoxic agents in mice
R. Seigers et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
The Markers of Glutamate Metabolism in Peripheral Blood Mononuclear Cells and Neurological Complications in Lung Cancer Patients
Slawomir Michalak et al.
DISEASE MARKERS (2016)
Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer
Debra E. Lyon et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Cognitive Impairment in a Subset of Breast Cancer Patients After Systemic Therapy-Results From a Longitudinal Study
Sanne Menning et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2016)
APOE genotype and stress response - a mini review
Janina Dose et al.
LIPIDS IN HEALTH AND DISEASE (2016)
Naringin and Sertraline Ameliorate Doxorubicin-Induced Behavioral Deficits Through Modulation of Serotonin Level and Mitochondrial Complexes Protection Pathway in Rat Hippocampus
Mohit Kwatra et al.
NEUROCHEMICAL RESEARCH (2016)
Functional connectivity change of brain default mode network in breast cancer patients after chemotherapy
Hui Miao et al.
NEURORADIOLOGY (2016)
A clinically relevant dose of cyclophosphamide chemotherapy impairs memory performance on the delayed spatial alternation task that is sustained over time as mice age
Michelle C. Janelsins et al.
NEUROTOXICOLOGY (2016)
Decline in Cognitive Function in Older AdultsWith Early-Stage Breast Cancer After Adjuvant Treatment
Marie Lange et al.
ONCOLOGIST (2016)
Acute treatment with doxorubicin induced neurochemical impairment of the function of dopamine system in rat brain structures
Lucyna Antkiewicz-Michaluk et al.
PHARMACOLOGICAL REPORTS (2016)
Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors
Shelli R. Kesler et al.
JAMA ONCOLOGY (2016)
Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice
Wenjun Zhou et al.
PLOS ONE (2016)
Vulnerabilities in Older Patients when Cancer Treatment is Initiated: Does a Cognitive Impairment Impact the Two-Year Survival?
Yves Libert et al.
PLOS ONE (2016)
Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study
Y. T. Cheung et al.
ANNALS OF ONCOLOGY (2015)
The Use of Anthracyclines for Therapy of CNS Tumors
Martina Ros et al.
Anti-Cancer Agents in Medicinal Chemistry (2015)
Doxorubicin and cyclophosphamide treatment produces anxiety-like behavior and spatial cognition impairment in rats: Possible involvement of hippocampal neurogenesis via brain-derived neurotrophic factor and cyclin D1 regulation
Yoshihisa Kitamura et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Chemobrain: A critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy
Xiao-Min Wang et al.
CYTOKINE (2015)
Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study
Lisa M. Hess et al.
GYNECOLOGIC ONCOLOGY (2015)
Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy
Myrle M. Stouten-Kemperman et al.
HUMAN BRAIN MAPPING (2015)
TODAY'S OXIDATIVE STRESS MARKERS
Marta Czerska et al.
MEDYCYNA PRACY (2015)
Cognitive Impairment after Chemotherapy Related to Atypical Network Architecture for Executive Control
Jay F. Piccirillo et al.
ONCOLOGY (2015)
Cognitive impairment in testicular cancer survivors 2 to 7 years after treatment
Ali Amidi et al.
SUPPORTIVE CARE IN CANCER (2015)
Impairment of cognitive function by chemotherapy: association with the disruption of phase-locking and synchronization in anterior cingulate cortex
Li Mu et al.
MOLECULAR BRAIN (2015)
Blood Brain Barrier: A Challenge for Effectual Therapy of Brain Tumors
Arijit Bhowmik et al.
BIOMED RESEARCH INTERNATIONAL (2015)
In vitro models for neurotoxicology research
Daniel Jose Barbosa et al.
TOXICOLOGY RESEARCH (2015)
Frontal hypometabolism in elderly breast cancer survivors determined by [18F] fluorodeoxyglucose (FDG) positron emission tomography (PET): a pilot study
Laura L. Boles Ponto et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2015)
Are Capecitabine and the Active Metabolite 5-FU CNS Penetrable to Treat Breast Cancer Brain Metastasis?
Jinqiang Zhang et al.
DRUG METABOLISM AND DISPOSITION (2015)
Dysregulation in myelination mediated by persistent neuroinflammation: Possible mechanisms in chemotherapy-related cognitive impairment
Teresita L. Briones et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Long-term cognitive function change among breast cancer survivors
Ying Zheng et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation
Mary K. Askren et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Cognitive Deficits in Korean Women Treated With Chemotherapy for Breast Cancer
Mi Sook Jung et al.
CANCER NURSING (2014)
Low-doses of cisplatin injure hippocampal synapses: A mechanism for 'chemo' brain?
Adrienne L. Andres et al.
EXPERIMENTAL NEUROLOGY (2014)
Cognition in patients with newly diagnosed brain metastasis: profiles and implications
Adam Gerstenecker et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)
Pieter J. Gaillard et al.
PLOS ONE (2014)
Altered Cerebral Blood Flow One Month after Systemic Chemotherapy for Breast Cancer: A Prospective Study Using Pulsed Arterial Spin Labeling MRI Perfusion
Kelly N. H. Nudelman et al.
PLOS ONE (2014)
Selective impairment of attention networks in breast cancer patients receiving chemotherapy treatment
Xingui Chen et al.
PSYCHO-ONCOLOGY (2014)
Electroencephalogram power changes as a correlate of chemotherapy-associated fatigue and cognitive dysfunction
Halle C. F. Moore et al.
SUPPORTIVE CARE IN CANCER (2014)
Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients
Juan Antonio Cruzado et al.
SUPPORTIVE CARE IN CANCER (2014)
Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls
Noriko Ando-Tanabe et al.
BREAST CANCER (2014)
A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients
Chris Lepage et al.
SPRINGERPLUS (2014)
The European Cancer and Work Network: CANWON
Angela G. E. M. de Boer
JOURNAL OF OCCUPATIONAL REHABILITATION (2014)
Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study
Brenna C. McDonald et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors
Shelli Kesler et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study
Rocio A. Lopez Zunini et al.
BRAIN IMAGING AND BEHAVIOR (2013)
Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study
Julie A. Dumas et al.
BRAIN IMAGING AND BEHAVIOR (2013)
Chemotherapy-related cognitive dysfunction: current animal studies and future directions
R. Seigers et al.
BRAIN IMAGING AND BEHAVIOR (2013)
Diffusion tensor MRI of chemotherapy-induced cognitive impairment in non-CNS cancer patients: a review
Sabine Deprez et al.
BRAIN IMAGING AND BEHAVIOR (2013)
The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer
K. L. Pomykala et al.
BRAIN IMAGING AND BEHAVIOR (2013)
Adverse Functional Effects of Chemotherapy on Whole-Brain Metabolism
Jordan Sorokin et al.
CLINICAL NUCLEAR MEDICINE (2013)
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Oktay Tacar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Chemobrain: A systematic review of structural and functional neuroimaging studies
Marta Simo et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls
Shelli R. Kesler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions
Christopher M. Nguyen et al.
PSYCHO-ONCOLOGY (2013)
Cognitive effects of chemotherapy in breast cancer patients: a dose-response study
Barbara Collins et al.
PSYCHO-ONCOLOGY (2013)
Chemotherapy-induced prospective memory impairment in patients with breast cancer
Huaidong Cheng et al.
PSYCHO-ONCOLOGY (2013)
Opening up the Window into Chemobrain: A Neuroimaging Review
Carole S. Scherling et al.
SENSORS (2013)
Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients. A pilot study
Federica Andreis et al.
SUPPORTIVE CARE IN CANCER (2013)
An old test for new neurons: refining the Morris water maze to study the functional relevance of adult hippocampal neurogenesis
Alexander Garthe et al.
FRONTIERS IN NEUROSCIENCE (2013)
Altered small-world properties of gray matter networks in breast cancer
S. M. Hadi Hosseini et al.
BMC NEUROLOGY (2012)
The effect of 5-fluorouracil on the long term survival and proliferation of cells in the rat hippocampus
Maha ELBeltagy et al.
BRAIN RESEARCH BULLETIN (2012)
Acute treatment with methotrexate induces hippocampal dysfunction in a mouse model of breast cancer
Miyoung Yang et al.
BRAIN RESEARCH BULLETIN (2012)
Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases
Joshua A. Smith et al.
BRAIN RESEARCH BULLETIN (2012)
Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy
Vincent Koppelmans et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study
N. Biglia et al.
EUROPEAN JOURNAL OF CANCER CARE (2012)
On the relationship between the default mode network and the social brain
Rogier B. Mars et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2012)
Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging
Michiel B. de Ruiter et al.
HUMAN BRAIN MAPPING (2012)
Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors
Jennifer Bruno et al.
NEUROBIOLOGY OF DISEASE (2012)
D-Methionine protects against cisplatin-induced neurotoxicity in cortical networks
Kamakshi V. Gopal et al.
NEUROTOXICOLOGY AND TERATOLOGY (2012)
Mechanism of Oxidative Stress in Neurodegeneration
Sonia Gandhi et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2012)
Fluoxetine Counteracts the Cognitive and Cellular Effects of 5-Fluorouracil in the Rat Hippocampus by a Mechanism of Prevention Rather than Recovery
Laura Lyons et al.
PLOS ONE (2012)
A prospective study of neuropsychological functioning in testicular cancer patients
T. Skaali et al.
ANNALS OF ONCOLOGY (2011)
Acute and Late Onset Cognitive Dysfunction Associated With Chemotherapy in Women With Breast Cancer
Kerstin Hermelink
CANCER (2011)
Catechol-O-Methyltransferase Genotype Modulates Cancer Treatment-Related Cognitive Deficits in Breast Cancer Survivors
Brent J. Small et al.
CANCER (2011)
Detection of doxorubicin hydrochloride accumulation in the rat brain after morphine treatment by mass spectrometry
Iacopo Sardi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: Implications for the reactive oxygen species-mediated mechanisms of chemobrain
Christopher D. Aluise et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Cerebral Hyporesponsiveness and Cognitive Impairment 10 Years After Chemotherapy for Breast Cancer
Michiel B. de Ruiter et al.
HUMAN BRAIN MAPPING (2011)
Chemotherapy-Induced Structural Changes in Cerebral White Matter and its Correlation With Impaired Cognitive Functioning in Breast Cancer Patients
Sabine Deprez et al.
HUMAN BRAIN MAPPING (2011)
Long-term Cognitive Impairment in Older Adult Twins Discordant for Gynecologic Cancer Treatment
Keiko Kurita et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2011)
DOXORUBICIN-INDUCED CENTRAL NERVOUS SYSTEM TOXICITY AND PROTECTION BY XANTHONE DERIVATIVE OF GARCINIA MANGOSTANA
J. Tangpong et al.
NEUROSCIENCE (2011)
Neurobiological basis of chemotherapy-induced cognitive impairment: A review of rodent research
Riejanne Seigers et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
Neuronal Nitric Oxide Synthase is a Key Factor in Doxorubicin-Induced Toxicity to Rat-Isolated Cortical Neurons
Miguel Angelo Lopes et al.
NEUROTOXICITY RESEARCH (2011)
The Effects of Cyclophosphamide on Hippocampal Cell Proliferation and Spatial Working Memory in Rat
Laura Lyons et al.
PLOS ONE (2011)
Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats
Jeffrey M. Long et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients
Catherine E. Jansen et al.
SUPPORTIVE CARE IN CANCER (2011)
The Relationship between Visuospatial Memory and Coping Strategies in Breast Cancer Survivors
Michelle Ayala-Feliciano et al.
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2011)
Identification of Mild Cognitive Impairments in Cancer Survivors
Mary Baxter et al.
OCCUPATIONAL THERAPY IN HEALTH CARE (2011)
Analysis of Memory Deficits Following Chemotherapy in Breast Cancer Survivors: Evidence from the Doors and People Test
Svetlana Prokasheva et al.
JOURNAL OF PSYCHOSOCIAL ONCOLOGY (2011)
Relationship Between Chemotherapy Use and Cognitive Impairments in Older Women With Breast Cancer Findings From a Large Population-Based Cohort
Xianglin L. Du et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2010)
The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study
Felice A. Tager et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study
Jeanne Debess et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Acute and Late Onset Cognitive Dysfunction Associated With Chemotherapy in Women With Breast Cancer
Jeffrey S. Wefel et al.
CANCER (2010)
Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates
Shana Jacobs et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
IGF-1 Partially Restores Chemotherapy-Induced Reductions in Neural Cell Proliferation in Adult C57BL/6 Mice
Michelle C. Janelsins et al.
CANCER INVESTIGATION (2010)
Recent Advances in Cancer Therapy: An Overview
A. Urruticoechea et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Cognitive functions in long-term survivors of ovarian cancer
Denise D. Correa et al.
GYNECOLOGIC ONCOLOGY (2010)
Neuropsychological Outcomes of Older Breast Cancer Survivors: Cognitive Features Ten or More Years After Chemotherapy
T. H. Yamada et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2010)
Measures of Cognitive Function and Work in Occupationally Active Breast Cancer Survivors
Lisseth Calvio et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2010)
Autophagy: cellular and molecular mechanisms
Danielle Glick et al.
JOURNAL OF PATHOLOGY (2010)
Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study
Kerstin Hermelink et al.
PSYCHO-ONCOLOGY (2010)
A Case of 5-Fluorouracil Induced Encephalopathy
Kyung A. Kwon et al.
CANCER RESEARCH AND TREATMENT (2010)
Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats
Riejanne Seigers et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Neuropsychological studies in breast cancer: in search of chemobrain
Steven Castellon et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Cognitive impairments associated with breast cancer treatments: results from a longitudinal study
Catherine Quesnel et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Cognitive Functioning in Breast Cancer Survivors: A Controlled Comparison
Heather S. L. Jim et al.
CANCER (2009)
The Effect of Modafinil on Cognitive Function in Breast Cancer Survivors
Sadhna Kohli et al.
CANCER (2009)
In vivo amelioration of adriamycin induced oxidative stress in plasma by gamma-glutamylcysteine ethyl ester (GCEE)
Christopher D. Aluise et al.
CANCER LETTERS (2009)
Cognitive Function in Breast Cancer Survivors Compared to Healthy Age- and Education-Matched Women
Diane Von Ah et al.
CLINICAL NEUROPSYCHOLOGIST (2009)
The Effects of Chemotherapy on Useful Field of View (UFOV) in Younger and Older Breast Cancer Patients
Carolyn E. Adams-Price et al.
EXPERIMENTAL AGING RESEARCH (2009)
Long-term cognitive function following chemotherapy in patients with testicular cancer
Anders Degn Pedersen et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2009)
Brain-derived neurotrophic factor in neurodegenerative diseases
Chiara Zuccato et al.
NATURE REVIEWS NEUROLOGY (2009)
Systemic administration of doxorubicin impairs aversively motivated memory in rats
Pedro Emanuel Rubini Liedke et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer
H. G. Mar Fan et al.
PSYCHO-ONCOLOGY (2009)
No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy
Mimi Mehlsen et al.
PSYCHO-ONCOLOGY (2009)
Cognitive and Psychological Factors Associated with Early Posttreatment Functional Outcomes in Breast Cancer Survivors
Stephanie A. Reid-Arndt et al.
JOURNAL OF PSYCHOSOCIAL ONCOLOGY (2009)
Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer
Sanne B. Schagen et al.
ACTA ONCOLOGICA (2008)
Redox regulation of cell survival
Dunyaporn Trachootham et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat
Riejanne Seigers et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Cognitive functions and elderly anticancer treatment: A cancer patients receiving prospective study
Alessandro M. Minisini et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Effect of epoetin alfa therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy
G. Iconomou et al.
EUROPEAN JOURNAL OF CANCER CARE (2008)
5-fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus
Sarah Mustafa et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment
Gaylia Jean Harry et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Patterns of dementia diagnosis in surveillance, epidemiology, and end results breast cancer survivors who use chemotherapy
Julia E. Heck et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
Chemobrain: A translational challenge for neurotoxicology
Bernard Weiss
NEUROTOXICOLOGY (2008)
Doxorubicin induces biphasic neurotoxicity to rat cortical neurons
Miguel Angelo Lopes et al.
NEUROTOXICOLOGY (2008)
The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study
Angela Stewart et al.
PSYCHO-ONCOLOGY (2008)
A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer
Helen G. Mar Fan et al.
SUPPORTIVE CARE IN CANCER (2008)
Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes
Celia M. Kassmann et al.
NATURE GENETICS (2007)
Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy
Daniel H. S. Silverman et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Collateral damage in cancer chemotherapy - Oxidative stress in nontargeted tissues
Yumin Chen et al.
MOLECULAR INTERVENTIONS (2007)
Cytokines, Inflammation, and Pain
Jun-Ming Zhang et al.
INTERNATIONAL ANESTHESIOLOGY CLINICS (2007)
Glutathione elevation by γ-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin:: Implication for chemobrain
Gururaj Joshi et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer
Val Shilling et al.
EUROPEAN JOURNAL OF ONCOLOGY NURSING (2007)
Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence
J. Richardson et al.
EUROPEAN JOURNAL OF CANCER CARE (2007)
Candidate mechanisms for chemotherapy-induced cognitive changes
Tim A. Ahles et al.
NATURE REVIEWS CANCER (2007)
Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients
Sanne B. Schagen et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)
Sanambar Sadighi et al.
BMC CANCER (2006)
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective
Arti Hurria et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Adriamycin-induced, TNF-α-mediated central nervous system toxicity
Jitanjong Tangpong et al.
NEUROBIOLOGY OF DISEASE (2006)
Cognitive impairment associated with adjuvant therapy in breast cancer
Catherine M. Bender et al.
PSYCHO-ONCOLOGY (2006)
Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: An electrophysiologic study
Baudewijntje P. C. Kreukels et al.
CLINICAL BREAST CANCER (2006)
A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer
V Jenkins et al.
BRITISH JOURNAL OF CANCER (2006)
Quality of life in patients with advanced gastric cancer treated with second-line chemotherapy
SH Park et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Medium-term effects of chemotherapy in older cancer patients
B Eberhardt et al.
SUPPORTIVE CARE IN CANCER (2006)
Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: A pilot prospective longitudinal study
Arti Hurria et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2006)
Intermediate dose 5-fluorouracil-induced encephalopathy
YA Kim et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2006)
The P300: Where in the brain is it produced and what does it tell us?
DEJ Linden
NEUROSCIENTIST (2005)
Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma
KA Donovan et al.
CANCER (2005)
Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy
BPC Kreukels et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome
CA Meyers et al.
CANCER (2005)
Cancer as a risk factor for long-term cognitive deficits and dementia
LH Heflin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
The effects of adjuvant chemotherapy on cognition in women with breast cancer - preliminary results of an observational longitudinal study
V Shilling et al.
BREAST (2005)
Mechanisms of Drug Resistance in Cancer Chemotherapy
Y. A. Luqmani
MEDICAL PRINCIPLES AND PRACTICE (2005)
Clinical pharmacokinetics of cyclophosphamide
ME de Jonge et al.
CLINICAL PHARMACOKINETICS (2005)
Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen
SA Castellon et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2004)
Oxidative stress in neurodegeneration: cause or consequence?
JK Andersen
NATURE MEDICINE (2004)
Estrogen- and tamoxifen-associated effects on brain structure and function
JL Eberling et al.
NEUROIMAGE (2004)
The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma - Results of a prospective, randomized, longitudinal trial
JS Wefel et al.
CANCER (2004)
The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy
TA Ahles et al.
PSYCHO-ONCOLOGY (2003)
Blood-brain barrier disruption in multiple sclerosis
A Minagar et al.
MULTIPLE SCLEROSIS JOURNAL (2003)
Overcoming the blood-brain barrier to taxane delivery for neurodegenerative diseases and brain tumors
A Rice et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2003)
Mitoxantrone in progressive multiple sclerosis:: a placebo-controlled, double-blind, randomised, multicentre trial
HP Hartung et al.
LANCET (2002)
5-fluorouracil-induced leukoencephalopathy in patients with breast cancer
SM Choi et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2001)
Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy
F Joly et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
